Background: Most colorectal cancer occurs due to lifestyle and increase age with only a minority of cases associated with underlying genetic disorders and environmental factors enables us to move in the direction of a complete assessment of disease risk. The objective of the present study was to compare between two different types of diverting stoma (loop ileostomy and transverse colostomy) as regard immediate and remote complications in patient with rectal cancer treated by restorative resection.Methods: A prospective randomized comparative clinical study was conducted on 50 patients who underwent anterior resection and low anterior resection for rectal cancer divided into two groups: Group I consisted of 25 patients who underwent by loop ileostomy. Group II consisted of 25 patients who underwent by loop transverse colostomy. All patients attended to surgical oncology unit of Sayed Galal hospital, Al Azhar University, Cairo, Egypt during the period from October 2018 to October 2019. Full history, routine, physical examination, routine and imaging investigations were done.Results: 80% and 84% of loop ileostomy and transverse colostomy patients had anterior resection, respectively with no statistically significant differences between the two studied groups regarding anterior resection. Patient who treated by loop ileostomy had deceased time of closure (5.2±0.25 weeks) and stay in hospital (5.16±1.65 and 3.29±0.55 days) than those treated by transverse colostomy (9.6±0.37 weeks) and (7.44±2.58 and 6.03±1.97 days) respectively.Conclusions: Egyptians have unique tumor characters and behavior, and different compliance with treatment regimens. Multicenter prospective studies, as well as evolving Egyptian treatment guidelines are needed to address this.
Background: Significant morbidity is associated with stoma creation and these complications can be grouped into early and late-occurring complications. The literature reports the rate of stoma-related complications ranging from 20 to 70%. Early complications occur within the first 30 days of the stoma creation and include ischemia/necrosis, retraction, mucocutaneous separation, and parastomal abscess.Objective: To evaluate complications of stoma after colorectal surgeries, both early and late complications of colostomy were assessed with respect to the frequency of complications, health-related quality of life (QoL), and length of hospitalization (LoH).
Patients and Methods:This was a randomized prospective trial evaluating early and late complications of colostomy after colorectal surgeries in Department of Surgical Oncology, Al-Azhar University Hospital. This study was started at June 2017 and ended at May 2019. Patients were included after they agree to be included in the study and an informed consent was taken. Screening for and inclusion of participants was made after the index surgery. Follow-up of patients was at the time of surgery and up to 6 months after index surgery. Fifty patients were included in this study and assessment of early and late complications was done. The risk of postoperative complications is dependent on patient-related factors and technical aspects of the operative procedure.Results: Retraction was found to be the most common complication (16 % of all patients). Parastomal herniation was the most common late complication after colostomy creation and it affected about 16% of all patients.
Conclusion:Complications from colostomies are frequent, costly, and difficult to resolve, even after multiple operations. Prevention of complications occurred through sufficient time spent in siting and mobilization, with strict attention to detail and a meticulous technique.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.